What Happened?
Dartmouth, NS-based Precision-BioLogic Appointed Philip Arlen as Chief Executive Officer
About the Company
Precision BioLogic is a Dartmouth, NS-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
About the Person
Dr. Philip M. Arlen, M.D. serves as the Chief Executive Officer of Precision Biologics, Inc. Dr. Arlen has been the Chief Executive Officer of Neogenix Oncology Inc., since March 2010 and its President and Chief Medical Officer since September 28, 2008. He focused on the clinical development program for Neogenix Oncology`s novel monoclonal antibody, NPC-1C, which was intended for the treatment of pancreatic cancer. In addition, he plays an integral role in the R&D effort overseeing the translation of Neogenix Oncology`s pipeline candidates into potential clinical products. He has more than 10 years of clinical oncology research experience. Prior to Neogenix, he served as Director of the Clinical Research Group for laboratory of Tumor Immunology and Biology at the National Cancer Institute in Bethesda, Maryland. Dr. Arlen is recognized internationally for his work in the field having received numerous awards and has published over 75 peer reviewed scientific papers on topics related to cancer immunology. He has been invited to present as a panelist and keynote speaker at major medical meetings around the world. He is a Board Certified Medical Oncologist with extensive clinical experience in Medical Oncology as well as cancer research in the field of Tumor Immunology. Dr. Arlen has been a Director of Neogenix Oncology Corporation since September 28, 2008. He received his BA from Emory University and his MD from Medical College of Georgia, School of Medicine.
Info Source
Press Release
Short Profile